Trastuzumab-Strf, also known as Herzuma, is a medication used in the treatment of certain types of cancer. It is a biosimilar to the drug Herceptin, and works by targeting a specific protein called HER2 that is found in some cancer cells. By binding to this protein, Trastuzumab-Strf can help to slow down or stop the growth of cancer cells.

This medication is commonly used in the treatment of breast cancer that is HER2-positive, as well as certain types of stomach cancer. It is typically given as an intravenous infusion, and the dosage and frequency of administration will vary depending on the specific type of cancer being treated.

As with any medication, Trastuzumab-Strf can cause side effects. Some common side effects may include nausea, vomiting, diarrhea, and fatigue. In some cases, more serious side effects such as heart problems or allergic reactions may occur. It is important to discuss any concerns or potential side effects with your healthcare provider before starting treatment with Trastuzumab-Strf.

Overall, Trastuzumab-Strf has been shown to be an effective treatment option for many patients with HER2-positive cancers. It is important to follow your healthcare provider’s instructions carefully and attend all scheduled appointments to ensure the best possible outcome. If you have any questions or concerns about Trastuzumab-Strf or your treatment plan, do not hesitate to reach out to your healthcare team for guidance and support.